Home > Analytics > DIVIS LABORATORIES

DIVIS LABORATORIES
Intrinsic Value | Fundamental Analysis

BOM : 532488     NSE : DIVISLAB    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Upward
Pledged Shares : None or < 25%
Sep 28,2022
Price(EOD): ₹ 3,705.55
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 98,382.35 Cr
Value of ₹ 1 Lac invested in DIVIS LABORATORIES
on Sep 28,2017 (price: ₹ 852.70)

₹ 1 L

₹ 4.35 L

1W : 3.5% 1M : 3.4% 1Y : -28.5%
COMMUNITY POLL
for DIVIS LABORATORIES
Please provide your vote to see the results
DIVIS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best 1M Momentum Large Cap Stocks
Industry Peers & Returns1W1M1Y
DIVIS LABORATORIES 3.5% 3.4% -28.5%
SUN PHARMACEUTICAL INDUSTRIES 1.2% 4.6% 16.5%
DR REDDYS LABORATORIES 2% 1.4% -13.7%
CIPLA 3.3% 7.9% 13.9%
GLAND PHARMA -5.7% -12.4% -46.5%
PIRAMAL ENTERPRISES -12.6% -55.9% -68.4%
CADILA HEALTHCARE 1.6% -2.3% -36.2%
TORRENT PHARMACEUTICALS -2.9% -3% -1.1%
ALKEM LABORATORIES 0.6% 13.1% -17.6%

FUNDAMENTAL ANALYSIS OF DIVIS LABORATORIES

 
Fundamentals Score
[ Q(TTM): Jun2022, Y: Mar2022
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]

Insights 💡 DIVISLAB is one of the top 18% companies with good fundamentals ! Discover More →

VALUATION OF DIVIS LABORATORIES

 
Valuation Score
[As on : Sep 28,2022 ]

Ratio Consolidated
P/E
P/B
P/S
31.68
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 3,105.35 Cr
[Latest Qtr - Jun2022 - Consolidated Results ]

8.39
P/B Calculated based on Book Value of Rs 11,728.20 Cr
[Latest Year - Mar2022 - Consolidated Results ]

10.63
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 9,253.71 Cr
[Latest Qtr - Jun2022 - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 17% undervalued companies ! Discover More →

FAIR VALUE OF DIVIS LABORATORIES

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
48%
48%
55%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF DIVIS LABORATORIES


Insights 💡 DIVISLAB is one of the top 18% companies with bullish price momentum currently! Discover More →

DIVIS LABORATORIES vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF DIVIS LABORATORIES

Year Debt/Equity ratio
Standalone Consolidated
2022
2021
2020
Avg_3yrs
0
0
0
-
0
0
0
-
[Last Annual Data : Mar2022]
Financial Ratios →

PLEDGED PROMOTER SHARES OF DIVIS LABORATORIES

Pledged Promoter Shares
0 %
As on : Jun2022

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF DIVIS LABORATORIES

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-10.48%
-23.34%
-20.86%
-21.53%
14.99%
-0.63%
4.52%
26.01%
QtrlyTrend
-2
Latest Qtr: Jun2022
Quarterly Result Analysis →


DIVIS LABORATORIES related INDICES

BSE Indices1W1M1Y
S&P BSE HEALTHCARE -1% 0.6% -13.9%
MFG -3.7% -3.3% -0.5%
S&P BSE DIVIDEND STABILITY -4.7% -5.7% -5%
S&P BSE SENSEX50 -4.8% -3.8% -5%
S&P BSE 100 -4.8% -3.7% -4.3%
NSE Indices1W1M1Y
NIFTY GROWTH SECTOR 15 1.2% 11.6% 9.1%
NIFTY PHARMA 1.1% 1% -11.7%
NIFTY HEALTHCARE 0.7% 1.5% -11.9%
NIFTY200 QUALITY30 -0.2% -1.5% -7.3%
NSE QUALITY 30 -1.3% -1.1% -6.2%

You may also like the below Video Courses


FAQ about DIVIS LABORATORIES


Is DIVIS LABORATORIES good for long term investment?

As on Sep 28,2022, the Fundamentals of DIVIS LABORATORIES look Strong and hence it may be good for long term investment! See Financial Performance of DIVIS LABORATORIES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is DIVIS LABORATORIES UnderValued or OverValued?

As on Sep 28,2022, DIVIS LABORATORIES is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of DIVIS LABORATORIES ?

As on Sep 28,2022, the Intrinsic Value of DIVIS LABORATORIES is Rs. 2,498.82 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 2,501.82
Fair Value [Median EV / Sales Model] : Rs. 2,498.82
Fair Value [Median Price / Sales Model] : Rs. 2,397.95
Estimated Median Fair Value of DIVIS LABORATORIES : Rs. 2,498.82

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is DIVIS LABORATORIES trading at a Premium or Discount?

As on Sep 28,2022, DIVIS LABORATORIES is trading at a Premium of 48% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].